Početna › Periferni T-stanični limfom › Texas › Houston
Kliničke studije za Periferni T-stanični limfom u gradu Houston, TX
9 studija za Periferni T-stanični limfom traži sudionike na lokacijama u gradu Houston i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
U tijeku regrutacijaFaza 1
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
U tijeku regrutacijaOpažajna studija
- Texas Children's Hospital, Houston
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
U tijeku regrutacijaFaza 1
- The University of Texas - MD Anderson Cancer Center, Houston
A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study
U tijeku regrutacijaFaza 2
- MD Anderson Cancer Center, Houston
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
U tijeku regrutacijaFaza 3
- MD Anderson Cancer Center, Houston
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
U tijeku regrutacijaFaza 1
- Md Anderson Cancer Center, Houston
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
U tijeku regrutacijaFaza 1/2
- Research Site, Houston
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
U tijeku regrutacijaFaza 3
- University of Texas, MD Anderson Cancer Center, Houston
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
U tijeku regrutacijaFaza 1
- The University of Texas MD Anderson Cancer Center, Houston
Studije za Periferni T-stanični limfom u drugim gradovima
- New York City, NY6 studija
- Boston, MA5 studija
- Baldwin Park, CA5 studija
- Philadelphia, PA4 studija
- Atlanta, GA4 studija
- Ann Arbor, MI3 studija
- Aurora, CO3 studija
- Columbus, OH3 studija
Ostale studije u gradu Houston
- Nemikrocelularni karcinom pluća145 studija
- Rak dojke126 studija
- Rak (sve vrste)121 studija
- Metastatski karcinom104 studija
- Kolorektalni rak102 studija
- Rak jajnika89 studija
- Akutna mijeloična leukemija85 studija
- Rak pluća78 studija
- Rak prostate76 studija
- Rak endometrija68 studija
- Rak gušterače61 studija
- Melanom59 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.